Condition: Patients With Non-Small Cell Lung Cancer · Sponsor: OSE Immunotherapeutics
Multicenter, randomized (2:1), open-label phase 3 study in HLA-A2 positive patients with squamous and non-squamous metastatic NSCLC with ICI secondary resistance. Patients will be randomized into 2 arms (randomization 2:1): experimental Arm A with OSE2101 monotherapy or control Arm B SoC with docetaxel monotherapy. Stratification factors will be histology (squamous versus non squamous) and ECOG Performance Status (0 versus 1).
This description comes directly from the study's public registry record.
Caroline Chevalier, MSc, MPH · +33 630 842 002 · caroline.chevalier@ose-immuno.com
Bérangère Vasseur, MD · +33 676 448 160 · berangere.vasseur@ose-immuno.com
Always discuss trial participation with your own doctor first.
| Clinical Research Advisors, LLC | Beverly Hills, California, United States | Recruiting |
| Clinical Research Advisors - Encino | Encino, California, United States | Active Not Recruiting |
| Clinical Research Advisors - West Hollywood | Los Angeles, California, United States | Active Not Recruiting |
| Clinical Research Advisors - Korea Town | Los Angeles, California, United States | Active Not Recruiting |
| SCL Health - Saint Joseph Hospital Cancer Center | Littleton, Colorado, United States | Withdrawn |
| Lutheran Medical Center - Cancer Centers of Colorado | Wheat Ridge, Colorado, United States | Recruiting |
| Eastern Connecticut Hematology and Oncology Associates | Norwich, Connecticut, United States | Recruiting |
| Georgetown Lombardi Comprehensive Cancer Center | Washington D.C., District of Columbia, United States | Recruiting |
| Comprehensive Hematology Oncology - Bradenton Clinic | Bradenton, Florida, United States | Active Not Recruiting |
| Comprehensive Hematology Oncology - Brandon Clinic | Brandon, Florida, United States | Active Not Recruiting |
| Cancer Specialists of North Florida - Fleming Island | Fleming Island, Florida, United States | Recruiting |
| Cancer Specialists of North Florida - Riverside | Jacksonville, Florida, United States | Recruiting |
+ 195 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06472245